White‑nose Syndrome (Bats) – A Patient‑Focused Guide

Overview

White‑nose syndrome (WNS) is a devastating fungal disease that affects hibernating *Myotis* (mouse‑eared) bats in North America. The disease is named for the characteristic white fungal growth that appears on the muzzle, ears, and wings of infected bats. WNS was first documented in 2006 in a cave in New York and has since spread to more than 38 U.S. states and 7 Canadian provinces, causing mortality rates of 70–100 % in some colonies.

Although the disease primarily threatens wildlife, understanding WNS is important for anyone who spends time in caves, mines, or other bat habitats, as the fungus can be inadvertently transported on clothing or gear and may have indirect public‑health implications (e.g., loss of natural insect control).

• Who it affects: Hibernating species of the genus Myotis (e.g., little brown bat, northern long‑eared bat) and a few non‑Myotis species.
• Prevalence: As of 2024, the fungus Pseudogymnoascus destructans has been confirmed in >15,000 caves/mines and is responsible for the decline of >10 million bats in the United States alone.^[1][2]
• Geographic range: Eastern, Midwestern, and Western North America; isolated detections in Europe (where the fungus is present but appears less lethal).

Symptoms

Unlike many human diseases, the “symptoms” of WNS are observed in the bat itself. If you are a wildlife rehabilitator, researcher, or park staff, look for the following signs during the hibernation period (October‑April):

Visible physical changes

• White fungal growth: Cotton‑like patches on the nose, ears, and wing membranes.
• Wing damage: Ulcerations, desiccation, or cracked wings that may appear pink or brown rather than the normal translucent membrane.

Behavioral and physiological signs

• Increased arousal frequency: Infected bats awaken from torpor more often, leading to premature depletion of fat reserves.
• Dehydration: Excessive water loss from damaged wing tissue.
• Weight loss: Noticeable emaciation despite still being in hibernacula.
• Abnormal flight: Weak, clumsy flight or inability to fly when the hibernation period ends.
• Mortality clusters: Large numbers of dead bats found near roost entrances.

Causes and Risk Factors

Primary cause

The disease is caused by the psychrophilic (cold‑loving) fungus Pseudogymnoascus destructans (formerly Geomyces destructans). The organism thrives at temperatures of 4–15 °C, which matches the environment of hibernacula.

Transmission pathways

• Direct contact: Bats spread spores through grooming and close roosting.
• Environmental reservoir: Spores persist on cave walls, guano, and equipment for months.
• Human‑mediated spread: Researchers, cavers, and tourists can transport spores on clothing, boots, and gear.

Risk factors for bat colonies

• Species that hibernate in large, cold, humid caves or mines.
• Colonies with high densities (crowding facilitates spread).
• Sites with limited airflow, which maintain optimal fungal growth temperatures.

Risk factors for humans

Humans do not become sick from P. destructans, but they can act as mechanical vectors. Anyone entering a known WNS site should consider decontamination protocols to protect bat populations.

Diagnosis

Diagnosis is performed by wildlife professionals, not by medical doctors treating human patients. The key steps are:

Field assessment

• Visual inspection: Look for the signature white growth on the nose/ears and wing lesions.
• Population monitoring: Compare counts before and after hibernation to detect abnormal mortality.

Laboratory confirmation

1. Swab sampling: Sterile cotton swabs are rubbed over the muzzle, ears, and wings.
2. Culture: Samples are grown on selective agar at 12 °C to isolate P. destructans.
3. Polymerase chain reaction (PCR): DNA amplification provides rapid, highly specific confirmation.
4. Histopathology (optional): Tissue sections examined under a microscope show characteristic fungal hyphae invading epidermal layers.

All sampling follows strict biosecurity guidelines to avoid contaminating other sites.

Treatment Options

There is currently no cure for WNS in wild bat populations, but several experimental and management strategies are being explored.

Environmental interventions

• Microclimate alteration: Raising temperature or reducing humidity in hibernacula can inhibit fungal growth, though this may also affect bat behavior.
• UV‑light treatment: Short‑wave UV exposure kills spores on surfaces; pilot studies show promise but logistical challenges remain.

Biological approaches

• Probiotic bacteria: Application of naturally occurring skin bacteria (e.g., Rhodococcus rhodochrous) that outcompete the fungus.
• Antifungal agents: Topical application of compounds such as itraconazole or chloramphenicol to individual bats has been tried in controlled settings, but widespread use is impractical.

Supportive care for rehabilitated bats

• Maintain warm, humid environments to reduce further fungal growth.
• Provide high‑calorie diets (e.g., mealworms) to rebuild fat stores.
• Isolate infected individuals to prevent spread to healthy populations.

Research & future therapies

Researchers are investigating genetic resistance, vaccine‑like approaches, and fungal‑specific RNA interference. None are yet approved for field use.

Living with White‑nose syndrome (bats)

While the disease does not affect humans directly, people who work with or live near bat colonies may need to adopt specific practices.

For cave‑workers, researchers, and volunteers

• Decontaminate gear: Use a 10% bleach solution or commercial disinfectant on boots, gloves, and equipment before leaving a site.
• Clothing protocol: Wear dedicated “cave clothes” that can be laundered at >60 °C after each use.
• Limit disturbance: Avoid entering known WNS hibernacula during the winter months unless essential.

For homeowners with bat roosts

• Do not attempt to remove bats in winter; contact local wildlife agencies for humane exclusion after the hibernation period.
• Seal entry points in the fall to prevent new colonies from forming.

Community involvement

Participate in citizen‑science programs that monitor bat populations (e.g., Bat Conservation International’s “Bat Count”). Reporting unusual mortality helps agencies allocate resources quickly.

Prevention

Because WNS spreads mainly via spores, preventing the introduction of the fungus to new sites is the most effective strategy.

• Follow agency guidelines: The U.S. Fish & Wildlife Service and the National Park Service provide “cave decontamination protocols” that must be adhered to.
• Restrict access: Close or limit human entry to known infected hibernacula during critical months (Nov–Mar).
• Educate the public: Signage at cave entrances describing WNS and proper gear cleaning.
• Support habitat restoration: Preserve and create summer roosting habitats (tree cavities, bat houses) to reduce crowding in winter sites.

Complications

If WNS is not managed, the following outcomes may occur:

• Colony collapse: Entire bat populations can disappear from a cave, reducing local biodiversity.
• Ecosystem impact: Bats consume up to 1,000 insects per hour; loss of bats can lead to increased agricultural pest populations and higher pesticide use.
• Economic losses: The U.S. agriculture sector incurs an estimated $3.7 billion annual loss attributed to reduced insect control by bats.^[3]
• Genetic bottleneck: Small surviving populations may lose genetic diversity, making future recovery harder.

When to Seek Emergency Care

References

• [1] Frick, W.F., et al. “An Emerging Disease Causes Regional Population Collapse of a Common North American Bat Species.” Science, 2010; 329(5992): 679‑682.
• [2] U.S. Fish & Wildlife Service. “White‑nose Syndrome.” 2024. https://www.fws.gov/white-nose-syndrome
• [3] Boyles, J.G., et al. “Economic Value of Bats in Pest Control.” Ecological Economics, 2022; 191: 107‑115.
• CDC. “Rabies – Bats.” 2023. https://www.cdc.gov/rabies/bats.html
• World Health Organization. “One Health: The Role of Wildlife in Emerging Infectious Diseases.” 2021.